Lombard Odier Asset Management (Switzerland) Sa Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

  • $1.14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$110.08 - $142.92 $19.3 Million - $25 Million
-175,176 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$99.73 - $148.48 $2.78 Million - $4.13 Million
-27,835 Reduced 13.71%
175,176 $24.1 Million
Q3 2021

Nov 12, 2021
SELL
$98.85 - $138.91 $6.66 Million - $9.36 Million
-67,347 Reduced 24.91%
203,011 $28.2 Million
Q2 2021

Aug 13, 2021
BUY
$65.78 - $105.02 $17.8 Million - $28.4 Million
270,358 New
270,358 $26.2 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email